These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 18986774)

  • 1. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal mood variation in outpatients with major depressive disorder.
    Morris DW; Trivedi MH; Fava M; Wisniewski SR; Balasubramani GK; Khan AY; Jain S; Rush AJ
    Depress Anxiety; 2009; 26(9):851-63. PubMed ID: 19306304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.
    Rush AJ; Zimmerman M; Wisniewski SR; Fava M; Hollon SD; Warden D; Biggs MM; Shores-Wilson K; Shelton RC; Luther JF; Thomas B; Trivedi MH
    J Affect Disord; 2005 Jul; 87(1):43-55. PubMed ID: 15894381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
    Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report.
    Bryan CJ; Songer TJ; Brooks MM; Thase ME; Gaynes BN; Klinkman M; Rush AJ; Trivedi MH; Fava M; Wisniewski SR
    J Affect Disord; 2008 May; 108(1-2):113-20. PubMed ID: 18037497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
    Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
    Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
    Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP; Tonnoir B; Ménard F; Galinowski A
    Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
    Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
    Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study.
    Perlis RH; Fraguas R; Fava M; Trivedi MH; Luther JF; Wisniewski SR; Rush AJ
    J Clin Psychiatry; 2005 Feb; 66(2):159-66; quiz 147, 273-4. PubMed ID: 15705000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
    Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ
    Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S; Bodlund O; Agren H
    J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insured and non-insured depressed outpatients: how do they compare?
    Lesser IM; Leuchter AF; Trivedi MH; Davis LL; Wisniewski SR; Balasubramani GK; Fava M; Rush AJ
    Ann Clin Psychiatry; 2007; 19(2):73-82. PubMed ID: 17612846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.
    Claassen CA; Trivedi MH; Rush AJ; Husain MM; Zisook S; Young E; Leuchter A; Wisniewski SR; Balasubramani GK; Alpert J
    J Affect Disord; 2007 Jan; 97(1-3):77-84. PubMed ID: 16824617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major depressive subtypes and treatment response.
    Fava M; Uebelacker LA; Alpert JE; Nierenberg AA; Pava JA; Rosenbaum JF
    Biol Psychiatry; 1997 Oct; 42(7):568-76. PubMed ID: 9376453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P; Legault M
    Depress Anxiety; 2008; 25(12):E173-81. PubMed ID: 19006260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B; Andersen HF; Dolberg OT
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
    Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
    Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problem-solving ability and comorbid personality disorders in depressed outpatients.
    Harley R; Petersen T; Scalia M; Papakostas GI; Farabaugh A; Fava M
    Depress Anxiety; 2006; 23(8):496-501. PubMed ID: 16845662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
    Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
    J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.